Keane Raymond T 4
4 · ARIAD PHARMACEUTICALS INC · Filed Dec 20, 2012
Insider Transaction Report
Form 4
Keane Raymond T
SVP General Counsel & CCO
Transactions
- Tax Payment
Common Stock
2012-12-18$20.18/sh−3,236$65,302→ 36,014 total - Exercise/Conversion
Common Stock
2012-12-18+7,750→ 39,250 total
Footnotes (2)
- [F1]Shares were acquired upon vesting of performance share units awarded on April 1, 2011.
- [F2]Represents shares withheld to satisfy withholding tax requirements related to the vesting of performance share units.